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Background: The lac operon provides cells with the ability to switch from glucose to lactose metabolism precisely
when necessary. This metabolic switch is mediated by the lac repressor (LacI), which in the absence of lactose
binds to the operator DNA sequence to inhibit transcription. Allosteric rearrangements triggered by binding of the
lactose isomer allolactose to the core domain of the repressor impede DNA binding and lift repression. In Nature,
the ability to detect and respond to environmental conditions comes at the cost of the encoded enzymes being
constitutively expressed at low levels. The readily-switched regulation provided by LacI has resulted in its
widespread use for protein overexpression, and its applications in molecular biology represent early examples of
synthetic biology. However, the leakiness of LacI that is essential for the natural function of the lac operon leads to
an increased energetic burden, and potentially toxicity, in heterologous protein production.
Results: Analysis of the features that confer promiscuity to the inducer-binding site of LacI identified tryptophan
220 as a target for saturation mutagenesis. We found that phenylalanine (similarly to tryptophan) affords a
functional repressor that is still responsive to IPTG. Characterisation of the W220F mutant, LacIWF, by measuring the
time dependence of GFP production at different IPTG concentrations and at various incubation temperatures
showed a 10-fold reduction in leakiness and no decrease in GFP production. Cells harbouring a cytotoxic protein
under regulatory control of LacIWF showed no decrease in viability in the early phases of cell growth. Changes in
responsiveness to IPTG observed in vivo are supported by the thermal shift assay behaviour of purified LacIWF with
IPTG and operator DNA.
Conclusions: In LacI, long-range communications are responsible for the transmission of the signal from the
inducer binding site to the DNA binding domain and our results are consistent with the involvement of position
220 in modulating these. The mutation of this single tryptophan residue to phenylalanine generated an enhanced
repressor with a 10-fold decrease in leakiness. By minimising the energetic burden and cytotoxicity caused by
leakiness, LacIWF constitutes a useful switch for protein overproduction and synthetic biology.
Keywords: Lactose repressor, Protein engineering, Mutagenesis, Differential scanning fluorimetry, Protein
production, Synthetic biology, Gene regulation, LacIBackground
Cellular metabolism has evolved to be energy efficient,
controllable and responsive to changes. The well-studied
lac operon is an example of how cells respond to envir-
onmental conditions to maximise their use of energy re-
sources [1-3]. In particular, the transcription repressor
LacI plays a pivotal role: in the absence of the energy
source lactose, LacI binds to the repressor binding site
(‘operator DNA’) and inhibits the transcription of genes* Correspondence: fh111@cam.ac.uk
Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK
© 2013 Gatti-Lafranconi et al.; licensee BioMed
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumrequired for lactose metabolism [4,5]. In the absence of
glucose (that acts as an inhibitor for the expression of
genes encoded in the lac operon), binding of the lactose
isomer allolactose triggers the release of LacI from the
operator DNA via an allosteric mechanism [4,6]. This
process shows the remarkable degree of coordination
achieved during evolution: i) protein production is trig-
gered by allolactose, which is itself formed from lactose
by β-galactosidase; ii) LacI regulates the expression of
proteins essential for uptake (by lactose permease) as
well as metabolism (by a group of enzymes that includes
β-galactosidase) of lactose; iii) the proteins encoded byCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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despite the high affinity of the interaction between LacI
and its operator DNA (Kd = 10 pM for the O
1 sequence
[7]); iv) the basal expression of the lac operon, referred
to as leakiness, is important for the function of the
regulatory system: the low levels of permease and β-
galactosidase that accumulate due to leakiness are
needed to generate enough allolactose to cause swit-
ching of LacI [1].
LacI is a popular choice for protein overexpression:
combined with the high-levels of transcription afforded
by RNA polymerases from phages [8], LacI has been
employed to uncouple the growth of the producing host
from protein production (usually in Escherichia coli, but
also in other organisms, including mammalian cells)
[9,10]. The pET/BL21 system, originally established in
1990 [11-13], is still widely used for protein overproduc-
tion. The key features that are necessary for the bio-
logical role of LacI in the regulation of the lac operon
are also the main limitations for its use in protein pro-
duction. Attempts to remedy the metabolic burden and
the cytotoxicity caused by leakiness in LacI-based ex-
pression systems include the introduction of additional
control elements in the cell (increased LacI expression
levels [14], co-expression of lysozyme [15], dual vectors
[16], inducible phage RNA polymerase in BL21-AIFigure 1 Binding promiscuity in the inducer binding pocket of LacI. A
[PDB:1LBH] (orange), [PDB:2PAF] (light blue) and [PDB:1EFA] (dark blue) sho
monomer of each structure is coloured in grey. IPTG (from structure 2P9H)
molecule effectors IPTG (2P9H and 1LBH) and ONPF (2PAF and 1EFA). Inter
(see Additional file 1: Table S1 for details) are shown. Structures follow the
tryptophan 220 is depicted in black. Note how 1LBH and 1EFA show IPTG
in 2P9H and 2PAF.cells [17]) or altered fermentation conditions such as
variations of temperature [18] and media composition
[19]. A comprehensive analysis of the challenges of
protein overproduction in E. coli can be found else-
where [20-24].
The LacI protein consists of two domains that bind
the operator DNA and the inducer (N-terminal and core
domain, respectively), a short C-terminal domain re-
quired for the formation of the homo-tetramer and a
hinge region between DNA and inducer binding do-
mains (Figure 1A) [25,26]. The protein has two equi-
librium states characterised by different degrees of
secondary structure in the DNA binding domain and
hinge region [27-29]. Binding of the inducer to the core
domain stabilises the non-binding conformation, cha-
racterised by local unfolding in the DNA binding do-
main (up to 40 Å away) that decreases specificity for the
lac operator and relieves the repression of transcription
[30]. Crystallisation in the presence of both inducers and
anti-inducers (IPTG and ONPF) has revealed the inter-
action networks in the binding pocket that correlate
with either repression or de-repression [31], and muta-
tional analysis has confirmed the importance of these
amino acids [32,33]. However, the effects of random mu-
tations [34-36] and insertions [37] in the LacI structure
as well as targeted mutations in the hinge region [38]. Superposition of LacI PDB structures [PDB:2P9H] (dark red),
wing the three-domain architecture of the protein. The second
is shown in black sticks. B. LacI binding pocket with the small
acting side chains as calculated by the DistancesRH pymol script
same colour-code and order as in panel A. The side chain of
and ONPF, respectively, bound in opposite orientations to those seen
Table 1 Amino acids at position 220 in naturally
occurring repressors and those identified from screening
the LacI W220X library
Naturally occurring Identified after
saturation mutagenesis
W LacI W
F EbgR CytR PurR F
S MalI S
L TreR L
P GalR GalS V
Y FruR ExuR I
T AraR M
C
Amino acids found in other repressors of the GalR/LacI family are listed in the
left column. Amino acids that allow LacI to retain the ability to bind to its
operator DNA, and thus repress expression, are listed in the right column (in bold
or italics to indicate whether they confer the I+ or Is phenotype, respectively).
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in long-distance allosteric transmission are still incom-
pletely understood. Furthermore, the construction of
chimeric repressors showed that specificity and function
could be retained by the individual domains despite
“mismatched interfaces” [39]. This observation points
to intra-domain connectivity as the source of allosteric
control. Protein engineering has brought about LacI var-
iants with altered inducibility: directed evolution yielded
variants with 100-fold tighter affinity for IPTG that car-
ried mutations in both the DNA and inducer binding
domains [40]. Similarly, mutations at positions 125 and
149 showed that changes at the inducer binding site in-
fluence the allosteric behaviour of LacI [32]. Mutants
that better repress transcription were obtained by direc-
ted evolution, but required the co-evolution of a new
operator DNA sequence [41].
The inducer binding site of LacI shows a remarka-
ble degree of plasticity and binding promiscuity (see
Figure 1B). Analysis of the amino acids in close proxim-
ity to the inducer/anti-inducer molecule in four crystal
structures (Additional file 1: Table S1) indicates the ex-
istence of a large overlap between the residues involved
in the binding of the two compounds. Among the clo-
sest amino acids, the tryptophan residue at position 220
establishes a large number of interactions with both sub-
strates, in both orientations. Although this observation
can partially be explained by the size of its bulky side
chain, an aromatic group at this position has been re-
ported to favour π-stacking in other repressors of the
GalR/LacI family (PurR [42]) and might play a role
in LacI as well (see ONPF binding in [PDB:1EFA],
Figure 1B). We investigated this hypothesis by substi-
tuting the large and bulky tryptophan residue at po-
sition 220 with all 20 amino acids.
We built a reporter system in which the green fluo-
rescent protein (GFP) is under the control of LacI in a
standard pET vector. The effects of mutations and of
fermentation conditions could then be monitored by
measuring the amounts of GFP produced per cell via cy-
tometry. Among tested variants, the LacI mutant W220F
(LacIWF) shows a wild type phenotype with an increased
dynamic range and a 10-fold reduction in leakiness.
The characterisation of time-, IPTG concentration- and
temperature-dependent GFP expression profiles together
with a qualitative comparison of binding affinities by
thermal shift analysis suggest that LacIWF exerts more
complete control of protein expression levels than LacI
and limits the detrimental effect leakiness has on the
host. LacIWF will be a valuable tool for heterologous pro-
tein expression in E. coli due to its ability to reduce
leakiness below detectable levels, its wider responsive-
ness to different IPTG concentrations and its compati-
bility with the traditional lac operator sequence.Results
Saturation mutagenesis at position 220
Natural repressors of the LacI family [43,44] show var-
iability in the type of the amino acid at position 220, with
a non-exclusive preference for bulky, hydrophobic and
aromatic side chains (Table 1). To test the effects on LacI
function of mutations at position 220, saturation muta-
genesis was performed at this position by means of whole
plasmid amplification with degenerate oligonucleotides
bearing an NNS codon. E. coli BL21(DE3) colonies carry-
ing a mutated LacI were grouped by their phenotype into
the following categories: I- for variants that have lost the
ability to bind DNA, Is for mutants that still bind the op-
erator but are incapable of induction, and I+ for variants
that are fully functional, so bind the operator in the ab-
sence of inducer and release repression in the presence of
inducer [35]. Approximately half of the library showed the
I- phenotype, while ~35% displayed an Is phenotype and
the remaining ~15% of the library was of the I+ phenotype.
Sequencing identified six amino acids that gave the Is
phenotype, whereas wild type Trp and Phe (found in other
repressors of the GalR/LacI family [43]) were the only
amino acids that led to DNA release upon IPTG addition
(Table 1). Using flow cytometry, the GFP expression of
cells bearing the sequenced LacI variants was determined,
and it was found that mutant W220F (LacIWF) has twice
the dynamic range (defined as the ratio between the fluo-
rescence of induced and un-induced cell cultures) of iden-
tically treated WT after overnight incubation at 37°C
(Figure 2). As expected, the Is variants gave expres-
sion levels in the range of noise.
LacI W220F is an effective regulator with low basal
expression levels
In LacI- and LacIWF-containing cells incubated at 37°C,
similar GFP production rates were observed in the
Figure 2 LacIWF affords higher GFP expression levels and lower
leakiness. The expression of GFP was quantified by flow cytometry
of E. coli cells carrying pLIGFP with the indicated mutations at
position 220. Cells were incubated overnight at 37°C and the
geometric mean of fluorescence measurements in the absence (blue
bars) and presence (orange bars) of IPTG (0.01 mM) is displayed as
arbitrary units (a.u.). To allow the comparison of data acquired on
different days, fluorescence values have been normalised against WT
(all mutants were tested under the same conditions and WT was
measured each time). The original flow cytometry histograms are
provided in Additional file 1: Figure S2.
Figure 3 GFP production kinetics for LacI and LacIWF. Cells
transformed with either pLIGFP (blue/cyan) or pLIGFP_W220F (red/
brown) were grown at 37°C in the presence (solid symbols) or
absence (open symbols) of IPTG. At regular intervals from the time
of induction (time 0), the cell culture was sampled for FACS (panel
A) or cell extract (panel B) analysis. The original flow cytometry
histograms are provided in Additional file 1: Figure S3.
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observed for cells bearing the mutant repressor in the
absence of the inducer (compared to those bearing LacI,
Figure 3A). Flow cytometry provides reliable population-
level data on expression that is represented by the mean
fluorescence of large datasets (> 30,000 events for each
point in our case), although the cell to cell variation
can be significant. Therefore, to confirm that the fluo-
rescence measured by FACS is representative of the
amounts of soluble and functional GFP that accumulates
in the cell, cell suspension aliquots (1 mL) were pelleted,
lysed and the fluorescence contained in the soluble pro-
tein fraction measured. As shown in Figure 3B, the same
conclusions about the behaviour of the W220F mutation
can be derived from the two types of analysis.
The primary objective of a protein over-expression
system is to generate the highest possible amount of
protein, although the ability to induce intermediate ex-
pression levels is sometimes desirable. While LacI-based
systems produce large amounts of protein, control over
the expression level is limited [24,45]. We thus tested
the effects of different IPTG concentrations on the rates
of GFP production (Figure 4A). If fluorescence values
after an overnight incubation are compared, LacIWF per-
forms as well as WT at 0.01 mM IPTG and outperforms
WT at 1 mM IPTG (as the mutant seems to benefit
from a slower decay of expressed protein after the ex-
pression peak). Protein production rates in the early,
linear phase (Figure 4B) are similar for LacI and LacIWF
at 1 mM IPTG, whereas at 0.01 mM inducer LacIWF has
a longer delay and slower rate of protein production.The observation of negligible GFP expression before in-
duction (Figure 4B) further suggests that mutant W220F
provides much tighter DNA binding in the absence of
IPTG. When protein production is performed at the
sub-optimal growth temperature of 25°C, the leakiness
of WT is significantly reduced, but remains considerably
above that of LacIWF (Figure 5).Mutant W220F has an expanded dynamic range
The dependence of GFP expression on IPTG concentra-
tion was tested using an end-point assay [45]: cells were
incubated in a multiwell-plate for 24 h with a range of
IPTG concentrations after which the fluorescence of the
cell suspension was measured directly. The rightward
shift of the curve for LacIWF in Figure 6 suggests that
this mutant has lower affinity for IPTG than the WT
protein. The shallower slope of the LacIWF induction
curve provides greater ‘tunability’ than offered by the
WT protein, which switches completely from uninduced
to fully induced within a 10-fold increase in IPTG
concentration. In contrast, the W220F mutant spreads
an equivalent increase in expression over a much
Figure 4 LacIWF outperforms WT at 1 mM IPTG. Cells bearing the
WT repressor (dark blue/blue/cyan) or the W220F mutant (dark red/
red/brown) were incubated in the absence (open symbols) of
inducer or in the presence of either 1 mM or 0.01 mM IPTG (dark
blue/dark red and blue/red, respectively). After overnight incubation
(panel A), the GFP production levels of WT and mutant are
indistinguishable by flow cytometry (but WT shows a marked
decrease in fluorescence at the highest IPTG concentration).
Although the final expression levels are similar, at early time points
(panel B) and with 0.01 mM IPTG, LacIWF shows a lag in induction
relative to the WT. Background expression levels are consistently
lower for the mutant, which shows no leakiness even before
induction (note the different fluorescence values for blue and red
lines in the grey-shaded area of panel B).
Figure 5 Lowering incubation temperature from 37°C to 25°C
does not affect leakiness in LacIWF. GFP expression levels were
measured on samples from cultures incubated without added IPTG
at either 37°C (filled circles) or 25°C (filled squares) for both WT (dark
blue/blue) and LacIWF (dark red/red). For the mutant, expression
levels in the absence of IPTG remain consistently 5-10 times lower
than WT during the overnight incubation and are only marginally
affected by temperature.
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a 100-fold increase in IPTG concentration to be fully
induced. However, the shape of the titration curve de-
pends heavily on growth conditions (see, for example,
the effect of temperature in Additional file 1: Figure S1).
The observation that a reduction in leakiness is accom-
panied by a wider dynamic range in LacIWF (note the dif-
ferent y-axis scales in Figure 6) stands in contrast to
mutants examined in previous reports [45]. At concentra-
tions above ~ 0.1 mM IPTG, LacIWF yields more protein
than WT LacI.
To probe the effects of leaky expression at levels below
those detectable by cytometry, we tested the growth
rates of cells bearing HIV protease under the control of
either WT LacI or LacIWF. A tethered dimer of HIV
protease [46], which cannot be produced in soluble formunder WT LacI control due to its toxicity [47,48],
was fused to maltose-binding protein (MBP) and
cloned in place of GFP to give plasmids pLIHP and
pLIHP_W220F. In the absence of the inducer, cells
transformed with the pLIHP_W220F plasmid showed
growth curves that are indistinguishable from those of
cells expressing GFP (Figure 7, panel A). In contrast,
when the expression of the MBP-HIV protease is
under the control of WT LacI, cells show slower growth
rates. This observation indicates that the leakiness of
LacIWF is reduced to levels at which even the expression
of the highly toxic HIV protease does not affect cell via-
bility. When 0.01 mM IPTG is added to the cell culture,
the growth of WT LacI is reduced further, while the
growth of LacIWF is not affected (Figure 7, panel B).
Stability of purified LacIWF corroborates in vivo results
The interaction between purified LacI (WT and LacIWF)
and either inducer or operator DNA was probed by ther-
mal shift assay. Thermal unfolding of purified proteins
was measured by differential scanning fluorimetry (DSF)
in the presence of IPTG or of the operator. To this end,
we expressed WT and LacIWF as C-terminal His6-tag
fusion proteins under the control of L-arabinose and
affinity-purified both proteins. Purified LacI and LacIWF
showed melting temperatures of 52.4±0.3°C and 49.1±
0.1°C, respectively, indicating a slight destabilisation of
the mutant (Figure 8). The addition of 1 mM IPTG
increases the melting temperature of WT by 7.6°C,
whereas LacIWF is stabilised to a slightly smaller extent
(+6.8°C). A similar trend is observed with 10 mM IPTG
(melting temperatures are 63.2±0.1°C and 58.1±0.1°C for
WT and mutant, respectively), indicating that IPTG is
Figure 6 LacIWF shows a wider dynamic range than WT. GFP expression levels measured on 200 μL of cell culture bearing LacI (blue, left axis)
or LacIWF (red, right axis) after 24 h incubation at 37°C with different IPTG concentrations. For each variant, three independent repeats were
corrected for cell density. The plot shows averaged values and standard deviation for each point. Curves have been drawn merely to guide the
eye. The two datasets are plotted on different axes to show the difference in dynamic range between LacI and LacIWF.
Figure 7 LacIWF reduces the cytotoxicity of a plasmid encoding
a MBP-HIV-protease. A. Optical density of BL21(DE3) cell cultures
bearing pLIGFP (blue line, open squares), pLIGFP_W220F (red line,
open squares), pLIHP (blue line, solid circles) or pLIHP_W220F (red
line, solid circles) in the absence of IPTG. B. Comparison of un-
induced (filled circles) and IPTG-induced (open circles) cells
expressing the MBP-HIV protease fusion under the control of LacI
(light/dark blue) or LacIWF (dark/light red). Cell cultures were induced
after 2 hours (black vertical line).
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stability of LacIWF. On the other hand, the addition of
2.5 μM operator DNA has a much larger effect on
LacIWF, which is stabilised by 12.8°C (in contrast to the
more modest 7.7°C increase in melting temperature for
WT LacI). The smaller extent of stabilisation by IPTG in
conjunction with better stabilisation by operator DNA is
consistent with the reduction in leakiness and in IPTG
sensitivity observed in vivo.
Discussion
Advances in structural and synthetic biology require a
better understanding of the consequences of protein
(over)expression and the development of more adaptable
production protocols. Despite the increase in efficiency
and robustness of in vitro expression systems [49-51],
bacteria (and E. coli in particular) still represent a very
common choice for protein production [52]. The im-
provements in yields and efficiency delivered via me-
tabolic engineering and synthetic biology [53-55] are
complemented by more analytical approaches that aim
to understand the properties that cause aggregation and
its effects on host viability [56-59]. As a result of these
efforts, a number of strains, fermentation conditions and
co-expression partners (such as chaperones or rare
tRNAs) can be used for high-throughput protein expres-
sion screening [60]. In particular, the ability to control
protein expression is of relevance, as the ideal system
would allow the user to choose whether yield, quality or
reduced toxicity are to be prioritised.
Although several approaches have been explored to
limit the basal expression rates of proteins under the
control of LacI [21], reducing leakiness through changes
Figure 8 LacIWF has increased stability in the presence of
operator DNA. Purified LacI and LacIWF were incubated at a final
concentration of 1 μM in the absence (grey) or presence of different
concentrations of IPTG (brown and dark red for 1 mM and 10 mM,
respectively) or operator DNA (2.5 μM, blue) and their unfolding
temperatures measured by DSF. The increase in melting
temperature caused by the presence of each ligand (ΔT) is reported
above the corresponding bar.
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proven to be remarkably difficult. Large-scale studies on
mutant libraries have helped to understand the struc-
tural features that allow LacI to be efficient at repressing
transcription and specific for both inducer and operator
DNA [35-37], but have rarely led to the isolation of bet-
ter mutants [40]. In LacI, long range communications
are responsible for the transmission of the signal from
the inducer binding side to the DNA binding domain
[30], as suggested by the effects of mutations in the
hinge region [38] and by the introduction of disulphide
bonds at positions 125, 149 and 193 [32,33]. Our results
show that saturation mutagenesis at position 220 gener-
ates the non-inducible Is phenotype in half of the cases,
whereas the ability to respond to IPTG is exclusive to
aromatic side chains (tryptophan and phenylalanine, see
Figure 2). Considering that binding of allolactose to LacI
would not benefit from aromatic interactions, the pres-
ence of tryptophan at position 220 is likely the result of
a compromise between tight binding of ligand and ef-
ficient repression. This view is consistent with the in-
volvement of position 220 in modulating long-range
communication between the inducer and DNA binding
sites.
The lac operon provides cells with the ability to switch
rapidly from glucose to lactose metabolism precisely
when necessary. This ability to detect and respond to
environmental conditions comes at the cost of the enco-
ded enzymes being constitutively expressed at low levels,
but the lac operon has found a way to balance energetic
cost and fast response. While the lac operon in its na-
tural context represents an impressive achievement of
natural evolution, the ability of the lac repressor touncouple transcription from cell growth has made it a
useful resource in protein production, and its applica-
tions in molecular biology represent an early example of
synthetic biology. Natural evolution has provided us
with a useful tool; however, man-made systems require
different properties that can be delivered by protein
engineering and directed evolution [61-63]. The
engineered repressor LacIWF minimises the energetic
burden prior to induction and growth inhibition by cyto-
toxic proteins and surpasses LacI in terms of maximal
GFP expression. LacIWF thus constitutes a useful switch
for protein overproduction and synthetic biology.
Conclusions
A single mutation, W220F, in the inducer-binding site
of LacI generates a fully functional repressor (named
LacIWF) with a 100-fold wider dynamic range at 37°C
and a 10-fold decrease in leakiness under all conditions
tested. The reduction in leakiness results in unimpaired
growth when toxic proteins are cloned under the control
of the mutant repressor. For IPTG concentrations above
0.1 mM, LacIWF yields more GFP than WT LacI, pos-
sibly due to a decrease in the rate of protein production
(in particular at low inducer concentrations). Data from
thermal shift assays indicate changes in the stabilisation
effects of IPTG and operator DNA on LacIWF compared
to WT LacI and, together with our in vivo analysis, are
suggestive of altered affinities in the mutant. In conclu-
sion, LacIWF is compatible with the conventional ope-
rator sequence, and has both reduced leakiness and an
improved dynamic range, so could be a superior alterna-
tive to the wild type repressor for controlling protein
expression.
Methods
Chemicals and growth media
All chemicals were of analytical grade and were pur-
chased from Sigma-Aldrich (unless otherwise stated). E.
coli strain Top10 was used for all standard cloning pro-
cedures. Protein expression was carried out in the BL21
(DE3) strain in Luria broth (LB) supplemented with
100 μg/mL ampicillin (LB-amp), agar (18 g/l) and IPTG,
when required. For a full list of primers used, see
Additional file 1: Table S2.
Construction of plasmids
Plasmid pLIGFP was constructed by cloning the se-
quence for a green fluorescent protein (GFP) variant
(bearing mutations S65G, V68L, S72A, Y203T and
H231L, [64,65]) into a modified pET22b vector. First,
the sequence of LacI was amplified with primers pLI01
and pLI02 to introduce the HindIII and NheI restrictions
sites, respectively, at positions 181 and 988 (via silent
mutations). This PCR product was purified and used as
Gatti-Lafranconi et al. Microbial Cell Factories 2013, 12:67 Page 8 of 10
http://www.microbialcellfactories.com/content/12/1/67a megaprimer in a second PCR reaction to yield plasmid
pLI. Subsequently, the GFP gene was amplified with
primers pLI05 and pLI06 to introduce NdeI and XhoI
sites, respectively and cloned into the double-digested
pLI plasmid to give pLIGFP (plasmid pLIGFP_W220F,
encoding for the LacIWF mutant, is available from
Addgene). Plasmids pLIHP and pLIHP_W220F were
built following the same procedure: MBP-HIV protease
fusion was amplified by PCR with primers pGMH2f
and pGMH3r and cloned in place of GFP in plasmids
pLIGFP and pLIGFP_W220F. All constructs were veri-
fied by sequencing. The standard PCR mix included 50
ng of template DNA, 250 nM of each dNTP, 0.5 μM of
each primer, and 0.5 U of PfuTurbo polymerase (Agilent)
in 20 μL of 1× Pfu buffer. Thermo-cycling consisted of
5 min at 95°C followed by 25 cycles of 30 sec at 95°C,
30 sec at 52°C and 1 min at 72°C, and a final extension
step of 10 min at 72°C. For the megapriming reaction,
the protocol was modified as follows: the PCR mix
contained 40 ng of pET22b plasmid and 300 ng of the
amplified LacI gene fragment in 50 μL of 1× Pfu buffer
and the cycling procedure was altered so that annealing
was carried out at 54°C for 45 sec and extension at 68°C
for 8 min.W220X library construction
Full randomisation of position 220 was achieved by
means of back-to-back primer PCR [66]. Full-plasmid
amplification of pLIGFP was carried out with primers
pLI07 (which contains the degenerate NNS codon) and
pLI08 and the linear DNA amplicon was treated with T4
Polynucleotide Kinase (200 ng of DNA with 5 U of
enzyme in 20 μL of 1× T4 Ligase buffer) for 30 min at
37°C. After lowering the temperature to 22°C, 400 U of
T4 Ligase were added to the mix and the reaction was
incubated for two additional hours. Aliquots of this reac-
tion were then used directly for transformation of com-
petent E. coli cells. The PCR reaction for full-plasmid
amplification consisted of 60 ng pLIGFP, 250 nM of each
dNTP, 0.5 μM of each primer, 1 U of PfuTurbo polymer-
ase (Agilent) in 50 μL of 1× Cloned Pfu buffer. Thermo-
cycling consisted of 10 min at 95°C followed by 25 cycles
of 30 sec at 95°C, 30 sec at 60°C and 8 min at 72°C, and
a final extension step of 10 min at 72°C.Growth conditions and fluorescence analysis
For all growth experiments, cells were pre-incubated
overnight at 37°C, diluted 1:50 into 5–50 mL of fresh
LB-amp, and then incubated at either 37°C or 25°C for
up to 26 h. For cytometry-based fluorescence analysis,
aliquots of 25 μL were sampled at the indicated times
and stored in 1 mL of PBS containing 0.5% formalde-
hyde. For each experiment, at least 30,000 events foreach sample were measured using a Becton Dickinson
FACScan Flow Cytometer and analysed with Flowing
Software. For consistency, data from a single representa-
tive experiment are plotted in each figure. Although this
treatment does not allow derivation of error bars, values
represent the average of > 30,000 events and errors are
expected to be minimised. Responsiveness to different
IPTG concentrations was measured by growing 1 mL
cultures of BL21(DE3) cells in multiwell plates for 24 h
at 37°C and then measuring OD600nm and fluores-
cence (excitation 485 nm, emission 527 nm) with a
M5 Spectramax microplate reader (Molecular De-
vices). To measure the fluorescence of cell extracts,
aliquots (1 mL) were sampled at the indicated times,
cells pelleted and frozen at −20°C prior to lysis in
200 mL of PBS containing BugBuster (1×) and Lysonase
(Millipore). After the removal of cell debris by centrifu-
gation, the fluorescence of the supernatant was mea-
sured in a plate reader.Arabinose-induced expression of LacI
Plasmid pBAD-LacI was constructed by cloning a mo-
dified LacI gene (amplified with primers pAL01 and
pAL02) into a NcoI and SalI double-digested pBADmyc-
hisB plasmid and verified by sequencing. The resulting
construct encodes for the lac repressor with a C-ter-
minal His6-tag (plasmid pBAD-LacI is available from
Addgene). Protein over-expression was carried out in
Top10 cells by addition of 0.2% (w/v) L-arabinose. After
4 h of expression at 20°C, cells were harvested, re-
suspended in lysis buffer (25 mM Tris–HCl, 300 mM
NaCl, 5 mM imidazole, pH 8) and 8 μL lysonase
(Novagen) and lysed by sonication. After centrifugation,
the soluble extract was affinity-purified on a 5 mL
HisTrap FF purification column (GE Healthcare) follo-
wing the manufacturer’s instruction and then buffer-
exchanged into LacI storage buffer (200 mM Tris–HCl,
200 mM KCl, 10 mM EDTA, 3 mM DTT, pH 7.4)
using two HiTrap buffer exchange columns (5 mL,
GE Healthcare) in sequence.Differential scanning fluorimetry
Purified proteins were diluted in LacI storage buffer at
the final concentration of 1 μM in the presence of 2×
SYPRO Orange (Invitrogen) and, when indicated, ei-
ther IPTG or the operator DNA (primers LacO1f and
LacO1r, corresponding to the O1 sequence [7], pre-
annealed) at the concentrations stated in the text. Melting
curves [67] were recorded in triplicate over the range
25°C to 95°C (1°C/min increases) with a real-time PCR
machine (Corbett Research Rotor-Gene 6000). Plotted
values are the average of three replicates.
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